Drooid Logo
Back to today’s briefing

Story perspectives

FDA Issues AI Lifecycle Guidance Amid Helium Supply Crisis

4/23/2026

44 10 Full Breakdown

1 of 2

Tarver Addresses AI Safety
  • Michelle Tarver, director of the FDA's Center for Devices and Radiological Health, announced final guidance on AI lifecycle management at neXus conference, addressing safety, transparency, and bias in AI-enabled devices.
  • Tarver emphasized training AI algorithms on relevant data and robust postmarket monitoring to ensure patient safety.
  • Moody’s Ratings warns that a helium supply crisis could disrupt AI infrastructure as Middle East disruptions threaten semiconductor production, risking AI growth.
1 / 2